Award

Ravulizumab IV Infusion

BELFAST HEALTH & SOCIAL CARE TRUST

This public procurement record has 3 releases in its history.

Award

13 Oct 2025 at 10:00

Award

24 Sep 2025 at 09:34

Award

24 Sep 2025 at 09:28

Summary of the contracting process

The recent procurement process completed by Belfast Health & Social Care Trust involved the direct award of a contract for the Ravulizumab IV Infusion, classified under the pharmaceutical products category. The procurement was based on a direct award method due to the availability of the medicines from only one economic operator, Alexion Pharma UK Limited, and addressed essential patient care needs. This process, governed by UK central government regulations and compliant with Northern Irish devolved laws, pertains to the Belfast region in the UKN06 area. Key dates include the contract's start on 9th October 2025, with completion expected by 30th September 2027, with an overall contract value of £1,200,000 GBP.

This tender creates substantial opportunities for businesses within the pharmaceutical industry, particularly those specialising in branded, patent-protected medicines. Although the procurement method was a direct award due to the lack of competitive alternatives, it highlights the critical demand for specialised pharmaceutical solutions that fulfil stringent health and regulatory standards. Large-scale pharmaceutical companies with intellectual property rights may find such opportunities lucrative, particularly those capable of providing specialised medical products directly to health authorities. These engagements could foster robust business growth, given the considerable contract value and the guaranteed need for essential medical supplies.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Ravulizumab IV Infusion

Notice Description

Procurement of Ravulizumab IV Infusion.

Procurement Information

These are branded patent protected medicines that are essential to patient care and are available from only one economic operator. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-05a0b7
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/064637-2025
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£1,200,000 £1M-£10M
Contracts Value
£1,200,000 £1M-£10M

Notice Dates

Publication Date
13 Oct 20254 months ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
23 Sep 20255 months ago
Contract Period
8 Oct 2025 - 30 Sep 2027 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
BELFAST HEALTH & SOCIAL CARE TRUST
Contact Name
Not specified
Contact Email
financeprocurement@belfasttrust.hscni.net
Contact Phone
Not specified

Buyer Location

Locality
BELFAST
Postcode
BT12 6BA
Post Town
Northern Ireland
Country
Northern Ireland

Major Region (ITL 1)
TLN Northern Ireland
Basic Region (ITL 2)
TLN0 Northern Ireland
Small Region (ITL 3)
TLN06 Belfast
Delivery Location
Not specified

Local Authority
Belfast
Electoral Ward
Falls
Westminster Constituency
Belfast West

Supplier Information

Number of Suppliers
1
Supplier Name

ALEXION PHARMA

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-05a0b7-2025-10-13T11:00:26+01:00",
    "date": "2025-10-13T11:00:26+01:00",
    "ocid": "ocds-h6vhtk-05a0b7",
    "initiationType": "tender",
    "parties": [
        {
            "id": "GB-PPON-PLQJ-5727-JCLR",
            "name": "Belfast Health & Social Care Trust",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PLQJ-5727-JCLR"
            },
            "address": {
                "streetAddress": "Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital",
                "locality": "Belfast",
                "postalCode": "BT12 6BA",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKN06"
            },
            "contactPoint": {
                "email": "FinanceProcurement@belfasttrust.hscni.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "classifications": [
                    {
                        "scheme": "UK_CA_TYPE",
                        "id": "publicAuthorityCentralGovernment",
                        "description": "Public authority - central government"
                    },
                    {
                        "scheme": "UK_CA_DEVOLVED_REGULATIONS",
                        "id": "GB-NIR",
                        "description": "Northern Irish devolved regulations apply"
                    }
                ]
            }
        },
        {
            "id": "GB-COH-05970106",
            "name": "ALEXION PHARMA UK LIMITED",
            "identifier": {
                "scheme": "GB-COH",
                "id": "05970106"
            },
            "additionalIdentifiers": [
                {
                    "scheme": "GB-PPON",
                    "id": "PQTX-1761-VLYY"
                }
            ],
            "address": {
                "streetAddress": "1 Francis Crick Avenue",
                "locality": "Cambridge",
                "postalCode": "CB2 0AA",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKH12"
            },
            "contactPoint": {
                "email": "UKMarketAccess@alexion.com"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large",
                "vcse": false,
                "publicServiceMissionOrganization": false,
                "shelteredWorkshop": false
            }
        }
    ],
    "buyer": {
        "id": "GB-PPON-PLQJ-5727-JCLR",
        "name": "Belfast Health & Social Care Trust"
    },
    "tender": {
        "id": "DACPM2025-41",
        "legalBasis": {
            "id": "2023/54",
            "scheme": "UKPGA",
            "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
        },
        "title": "Ravulizumab IV Infusion",
        "description": "Procurement of Ravulizumab IV Infusion.",
        "status": "complete",
        "procurementMethod": "direct",
        "procurementMethodDetails": "Direct award",
        "procurementMethodRationale": "These are branded patent protected medicines that are essential to patient care and are available from only one economic operator. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement.",
        "lots": [
            {
                "id": "1",
                "status": "complete"
            }
        ],
        "documents": [
            {
                "id": "conflictOfInterest",
                "documentType": "conflictOfInterest",
                "description": "Not published"
            }
        ],
        "procurementMethodRationaleClassifications": [
            {
                "id": "singleSuppliersIntellectualPropertyExclusiveRights"
            }
        ]
    },
    "awards": [
        {
            "id": "1",
            "title": "Ravulizumab IV Infusion",
            "status": "active",
            "value": {
                "amountGross": 1200000,
                "amount": 1200000,
                "currency": "GBP"
            },
            "mainProcurementCategory": "goods",
            "aboveThreshold": true,
            "suppliers": [
                {
                    "id": "GB-COH-05970106",
                    "name": "ALEXION PHARMA UK LIMITED"
                }
            ],
            "items": [
                {
                    "id": "1",
                    "additionalClassifications": [
                        {
                            "scheme": "CPV",
                            "id": "33600000",
                            "description": "Pharmaceutical products"
                        }
                    ],
                    "deliveryAddresses": [
                        {
                            "region": "UKN",
                            "country": "GB",
                            "countryName": "United Kingdom"
                        },
                        {
                            "region": "UKN",
                            "country": "GB",
                            "countryName": "United Kingdom"
                        },
                        {
                            "region": "UKN",
                            "country": "GB",
                            "countryName": "United Kingdom"
                        }
                    ],
                    "relatedLot": "1"
                }
            ],
            "contractPeriod": {
                "startDate": "2025-10-04T00:00:00+01:00",
                "endDate": "2027-09-30T23:59:59+01:00"
            },
            "relatedLots": [
                "1"
            ],
            "documents": [
                {
                    "id": "059118-2025",
                    "documentType": "awardNotice",
                    "noticeType": "UK5",
                    "description": "Transparency notice on Find a Tender",
                    "url": "https://www.find-tender.service.gov.uk/Notice/059118-2025",
                    "datePublished": "2025-09-24T10:28:32+01:00",
                    "format": "text/html"
                },
                {
                    "id": "059124-2025",
                    "documentType": "awardNotice",
                    "noticeType": "UK6",
                    "description": "Contract award notice on Find a Tender",
                    "url": "https://www.find-tender.service.gov.uk/Notice/059124-2025",
                    "datePublished": "2025-09-24T10:34:19+01:00",
                    "format": "text/html"
                }
            ],
            "milestones": [
                {
                    "id": "1",
                    "type": "futureSignatureDate",
                    "dueDate": "2025-10-04T23:59:59+01:00",
                    "status": "scheduled"
                }
            ],
            "date": "2025-09-24T00:00:00+01:00",
            "standstillPeriod": {
                "endDate": "2025-10-03T23:59:59+01:00"
            }
        }
    ],
    "language": "en",
    "contracts": [
        {
            "id": "1",
            "awardID": "1",
            "title": "Ravulizumab IV Infusion",
            "status": "active",
            "period": {
                "startDate": "2025-10-09T00:00:00+01:00",
                "endDate": "2027-09-30T23:59:59+01:00"
            },
            "value": {
                "amountGross": 1200000,
                "amount": 1200000,
                "currency": "GBP"
            },
            "aboveThreshold": true,
            "dateSigned": "2025-10-09T00:00:00+01:00",
            "noAgreedMetricsRationale": "The contract value is below the relevant threshold for key performance indicators.",
            "documents": [
                {
                    "id": "064637-2025",
                    "documentType": "contractNotice",
                    "noticeType": "UK7",
                    "description": "Contract details notice on Find a Tender",
                    "url": "https://www.find-tender.service.gov.uk/Notice/064637-2025",
                    "datePublished": "2025-10-13T11:00:26+01:00",
                    "format": "text/html"
                }
            ]
        }
    ]
}